RNA-transfection of γ/δ T cells with a chimeric antigen receptor or an α/β T-cell receptor: a safer alternative to genetically engineered α/β T cells for the immunotherapy of melanoma

Peer Review reports

Original Submission
6 Mar 2017	Submitted	Original manuscript
15 Apr 2017	Reviewed	Reviewer Report - Xiaotao Jiang
16 Apr 2017	Reviewed	Reviewer Report - Zong Sheng Guo
16 Apr 2017	Reviewed	Reviewer Report - Yukai He
14 Jun 2017	Author responded	Author comments - Dennis Harrer
Resubmission - Version 2
14 Jun 2017	Submitted	Manuscript version 2
17 Jul 2017	Author responded	Author comments - Dennis Harrer
Resubmission - Version 3
17 Jul 2017	Submitted	Manuscript version 3
27 Jul 2017	Author responded	Author comments - Dennis Harrer
Resubmission - Version 4
27 Jul 2017	Submitted	Manuscript version 4
3 Aug 2017	Author responded	Author comments - Dennis Harrer
Resubmission - Version 5
3 Aug 2017	Submitted	Manuscript version 5
Publishing
10 Aug 2017	Editorially accepted
17 Aug 2017	Article published	10.1186/s12885-017-3539-3

Back to article page